Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep-Oct;38(5):213-218.
doi: 10.11138/gchir/2017.38.5.213.

Study of the role of telomerase in colorectal cancer: preliminary report and literature review

M Minafra, R Laforgia, M G Sederino, S Fedele, A Delvecchio, S Lattarulo, G Carbotta, G Fabiano
Review

Study of the role of telomerase in colorectal cancer: preliminary report and literature review

M Minafra et al. G Chir. 2017 Sep-Oct.

Abstract

Aim: The aim of our study is to focus on hTERT (human Telomerase Reverse Transcriptase) expression to identify tumoral tissue after a comparison to TP53 and KRAS. More than 85% of cancer cells contain genetic aberrations and also overexpression of hTERT, and, in fact, the promoter of hTERT characterizes all malignant cells.

Patients and methods: Our sample is composed of 18 patients, including 10 with CRC that underwent surgical procedure and 8 patients without CRC, which represent the control group. The hTERT gene expression, KRAS and p53 were evaluated by methodical Real Time - PCR on RNA extracted from tumor tissues, peritumoral tissue and control cases.

Results: Within the CRC group the evaluation of the tumor tissue showed an increase of hTERT expression with a statistical significance (> 0.1) in 5 of these, also associated with substantial increase of KRAS (> 0.2). The peritumoral tissue assessment showed important increase in KRAS in 4 patients (> 0.2), while hTERT is not found to be particularly increased. The value of p53 did not show any particular significance (<0.1).

Discussion: The analysis of our data leads us to consider that the increase of hTERT is evident in patients suffering from CRC and that some of them will become significant in relation to the increase of KRAS and independent of p53. In peritumoral tissues, however, KRAS increases considerably, instead hTERT maintains a low concentration and this is compatible with the cellular evolution of the neoplastic tissue adjacent to the tumor.

Conclusions: hTERT could be used for diagnosis and prognosis in the future, to be able to identify the risk of tumor progression and to set up an adequate therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gene expression of hTERT, p53, Kras in tumor tissue.
Figure 2
Figure 2
Gene expression of hTERT, p53, Kras in peritumoral tissue.
Figure 3
Figure 3
Gene expression of hTERT, p53, Kras in healthy patients.
See this image and copyright information in PMC

References

    1. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352:476–487. - PubMed
    1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30. - PubMed
    1. Yu-Zhou Q, Xue-Cheng X, Hai-Zhou L, et al. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer. Oncology reports. 2015;33:2733. - PMC - PubMed
    1. Zecchin D, Boscaro V, Medico E, Barault L, et al. BRAF V600E Is a Determinant of Sensitivity to Proteasome Inhibitors. Mol Cancer Ther. 2013;12(12):2950–2961. - PubMed
    1. Kelland L. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin Cancer Res. 2007;13:4960–4963. - PubMed